MedTrace Logo

Radiation Therapy With or Without Goserelin and Cyproterone in Treating Patients With Prostate Cancer

NCT00849082 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2012-07-11

No results posted yet for this study

Summary

RATIONALE: Radiation therapy uses high energy x rays to kill tumor cells. This may be an effective treatment for prostate cancer. Androgens can cause the growth of prostate cancer cells. Antihormone therapy, such as goserelin and cyproterone, may lessen the amount of androgens made by the body and reduces the amount of androgens available to the body. It is not yet know whether radiation therapy alone is more effective than radiation therapy given together with goserelin and cyproterone in treating patients with prostate cancer.

PURPOSE: This randomized phase III trial is studying radiation therapy to see how well it works compared to giving radiation therapy together with goserelin and cyproterone in treating patients with prostate cancer that is at high risk for metastasis.

Conditions

Interventions

DRUG

cyproterone acetate

DRUG

goserelin acetate

RADIATION

radiation therapy

Sponsors & Collaborators

  • European Organisation for Research and Treatment of Cancer - EORTC

    lead NETWORK

Principal Investigators

  • Michel Bolla, MD · CHU de Grenoble - Hopital de la Tronche

Study Design

Purpose
TREATMENT

Eligibility

Max Age
79 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1987-05-31
Primary Completion
1995-11-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00849082 on ClinicalTrials.gov